Development and validation of a nomogram to predict sarcopenia risk in patients with chronic kidney disease

Read full text Summarise with VIRAT
Authors: Fan Dong-yue, Li Yun-long, Wang Ke-xin, Tian Zhao-xing, Zhang Dong-liang, Li Si-qi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

ObjectiveTo identify independent risk factors for sarcopenia in patients with chronic kidney disease (CKD) and to develop and validate a clinical risk‑prediction nomogram.MethodsWe retrospectively enrolled 350 CKD patients admitted to Beijing Jishuitan Hospital, Capital Medical University from May 1, 2022 to May 31, 2024 as the derivation cohort by simple random sampling. An external validation cohort comprised 180 CKD patients from Peking University Third Hospital. Potential predictors were screened using univariate analysis and then entered into multivariable logistic regression to identify independent risk factors. A nomogram was constructed from the final model. Discrimination was assessed by receiver operating characteristic (ROC) curve analysis (AUC) for internal and external validation; calibration was evaluated with the Hosmer-Lemeshow test.ResultsThe overall sarcopenia prevalence in the derivation cohort was 13.71%(48/350). Independent predictors of sarcopenia were: current diuretic use (OR=11.485, 95%CI:1.192-110.68), older age (OR=1.229, 95%CI:1.078-1.402), elevated high-sensitivity C-reactive protein(hs-CRP) (OR=9.157,95%CI:2.267-36.985),higher interleukin-6(IL‑6)(OR=2.113,95%CI:1.263-3.535), increased β2‑microglobulin(OR=1.566, 95%CI:1.164-2.107), higher depression self‑rating score(OR=2.115, 95%CI:1.404-3.185), lower Montreal Cognitive Assessment(MoCA) score(protective;OR=0.344,95%CI:0.183-0.648), and higher Charlson Comorbidity Index(OR=3.525,95%CI:1.493-8.322). The nomogram demonstrated excellent discrimination:AUC=0.991(95%CI:0.983-0.999) in internal validation and AUC=0.990(95%CI:0.980-1.000) in external validation.Calibration was very good (Hosmer-Lemeshow χ2=1.869,P=0.985 for internal validation;χ2=1.866,P=0.989 for external validation).ConclusionWe developed a well‑calibrated nomogram that accurately predicts sarcopenia risk in CKD patients using readily obtainable clinical and laboratory variables. This tool may facilitate early identification of high‑risk patients and guide targeted prevention and management strategies.

Fields of Study & Subjects

Nutrition and Health in Aging Dialysis and Renal Disease Management Chronic Kidney Disease and Diabetes

Publication details

Journal / source
DOAJ (DOAJ: Directory of Open Access Journals)
Publication date
1 March 2026
Language
ZH